Mariner
SWTX

Mariner’s SpringWorks Therapeutics SWTX Stock Holding History

Mariner’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-9,241
Closed -$408K – 3684
2025
Q1 		$408K Buy
9,241
+268
+3% +$12.3K ﹤0.01% 2367
2024
Q4 		$324K Sell
8,973
-150
-2% -$5.24K ﹤0.01% 2560
2024
Q3 		$292K Sell
9,123
-38
-0.4% -$1.42K ﹤0.01% 2589
2024
Q2 		$345K Buy
9,161
+2,451
+37% +$103K ﹤0.01% 2342
2024
Q1 		$330K Buy
6,710
+677
+11% +$31.3K ﹤0.01% 2358
2023
Q4 		$220K Buy
+6,033
New +$157K ﹤0.01% 2614

Other funds holding SWTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Mariner's SWTX Position: Q2 2025 in Review

Mariner sold out of SpringWorks Therapeutics (SWTX) in Q2 2025, closing a stake of 9,241 shares — an estimated $408K sold.

Mariner first reported a position in SWTX in Q4 2023 and held it in 6 quarters. The position peaked at $408K in Q1 2025. 223 funds tracked by Wall St. Rank hold SWTX as of Q2 2025.

  • Mariner reported no remaining SpringWorks Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Mariner sold 9,241 SpringWorks Therapeutics shares in Q2 2025, an estimated $408K.
  • Mariner first reported a position in SpringWorks Therapeutics in Q4 2023 and held it in 6 quarters.
  • Mariner's SpringWorks Therapeutics position peaked at $408K in Q1 2025.
  • 223 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2025.

Based on Mariner's 13F filing for Q2 2025, filed 14 Aug 2025.